Ambros Therapeutics

Series-A
ambrostherapeutics.com Biotech & Healthcare Irvine, United States Founded 2024 11–50 employees
Total Funding $125M
Latest Round $125M Series-A
Last Announced Dec 16, 2025
Investors 9 Backers
Decision Makers Profile Active

About Ambros Therapeutics

Ambros Therapeutics is a clinical-stage biotechnology company.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Irvine, United States
Year Founded 2024
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website ambrostherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $125,000,000 · Series-A

    Backed by Patient Square Capital

  2. Milestone

    Company founded

    Irvine, United States

Investors & Backers

9
Patient Square Capital
Lead
Abiogen Pharma
Adage Capital Management
Arkin Bio Ventures
Balyasny Asset Management
Janus Henderson Investors
LifeSci Venture Partners
RA Capital Management
Transhuman Capital

Funding History

1 Round
Series-A equity · Dec 16, 2025

Round backers: Patient Square Capital

Founders & Leadership

4

Gail Cawkwell

CMO

Work email & phone locked Unlock →

Joseph Hagan

President and Chief Executive Officer

Work email & phone locked Unlock →

Kunal Kishnani

Founder

Work email & phone locked Unlock →

Michael Cruse

COO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts